Emergent BioSolutions (EBS) Short Interest Ratio & Short Volume → Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad) Free EBS Stock Alerts $1.90 -0.05 (-2.56%) (As of 04/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Emergent BioSolutions Short Interest DataCurrent Short Volume5,700,000 sharesPrevious Short Volume4,910,000 sharesChange Vs. Previous Month+16.09%Dollar Volume Sold Short$14.42 millionShort Interest Ratio / Days to Cover1.9Last Record DateMarch 31, 2024Outstanding Shares52,390,000 sharesFloat Size50,070,000 sharesShort Percent of Float11.38%Today's Trading Volume691,333 sharesAverage Trading Volume1,007,282 sharesToday's Volume Vs. Average69% Short Selling Emergent BioSolutions ? Sign up to receive the latest short interest report for Emergent BioSolutions and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEBS Short Interest Over TimeEBS Days to Cover Over TimeEBS Percentage of Float Shorted Over Time Ad Paradigm PressCould Bitcoin Literally FORCE This Crypto To Rocket Up?Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. Emergent BioSolutions Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20245,700,000 shares $14.42 million +16.1%11.4%1.9 $2.53 3/15/20244,910,000 shares $12.00 million -20.8%9.8%1.6 $2.45 2/29/20246,200,000 shares $19.96 million -46.3%12.5%2.1 $3.22 2/15/202411,540,000 shares $19.68 million +10.5%23.2%4.2 $1.71 1/31/202410,440,000 shares $17.43 million -11.7%21.0%7.8 $1.67 1/15/202411,820,000 shares $24.23 million +1.3%23.8%8.6 $2.05 Get the Latest News and Ratings for EBS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emergent BioSolutions and its competitors with MarketBeat's FREE daily newsletter. 12/31/202311,670,000 shares $28.01 million +3.0%23.5%8.4 $2.40 12/15/202311,330,000 shares $26.85 million +0.8%22.8%7.8 $2.37 11/30/202311,240,000 shares $24.05 million +4.3%22.6%6.6 $2.14 11/15/202310,780,000 shares $23.82 million -1.4%21.7%5.1 $2.21 10/31/202310,930,000 shares $22.84 million +21.9%22.0%4.7 $2.09 10/15/20238,970,000 shares $22.60 million +14.1%18.1%3.7 $2.52 9/30/20237,860,000 shares $26.72 million -16.9%15.8%3.3 $3.40 9/15/20239,460,000 shares $37.27 million +12.8%19.0%4 $3.94 8/31/20238,390,000 shares $39.35 million -9.3%16.8%3.9 $4.69 8/15/20239,250,000 shares $48.01 million +5.4%18.6%5.6 $5.19 7/31/20238,780,000 shares $60.36 million +5.0%18.1%5.8 $6.88 7/15/20238,360,000 shares $60.28 million +8.3%17.2%6.2 $7.21 6/30/20237,720,000 shares $56.66 million +9.8%15.9%5.3 $7.34 6/15/20237,030,000 shares $56.91 million +3.7%16.2%3.9 $8.10 5/31/20236,780,000 shares $57.83 million +6.8%15.5%3.9 $8.53 5/15/20236,350,000 shares $58.99 million -4.5%14.4%3.4 $9.29 4/30/20236,650,000 shares $58.72 million -7.5%15.1%3.7 $8.83 4/15/20237,190,000 shares $85.20 million -5.4%17.7%4.2 $11.85 3/31/20237,600,000 shares $78.74 million +22.4%18.7%4.6 $10.36 3/15/20236,210,000 shares $59.93 million +11.7%15.3%5.5 $9.65 2/28/20235,560,000 shares $68.83 million -1.1%13.7%5.1 $12.38 2/15/20235,620,000 shares $83.85 million No Change13.9%5.6 $14.92 1/31/20235,620,000 shares $74.13 million +4.9%13.9%5.7 $13.19 1/15/20235,360,000 shares $71.98 million -3.8%13.2%5.4 $13.43 12/30/20225,570,000 shares $65.78 million +63.3%13.7%5.8 $11.81 12/15/20223,410,000 shares $37.99 million +45.7%8.4%3.7 $11.14 11/30/20222,340,000 shares $28.78 million -9.0%5.7%2.9 $12.30 11/15/20222,570,000 shares $34.21 million +19.0%6.3%3.4 $13.31 10/31/20222,160,000 shares $45.06 million +6.4%5.3%3.4 $20.86 10/15/20222,030,000 shares $39.44 million -9.4%5.0%3.1 $19.43 9/30/20222,240,000 shares $47.02 million +9.3%5.5%3.4 $20.99 9/15/20222,050,000 shares $47.27 million +5.1%5.0%3.3 $23.06 8/31/20221,950,000 shares $46.84 million -34.8%4.8%3.1 $24.02 8/15/20222,990,000 shares $91.20 million -15.3%7.3%4.2 $30.50Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. EBS Short Interest - Frequently Asked Questions What is Emergent BioSolutions' current short interest? Short interest is the volume of Emergent BioSolutions shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 5,700,000 shares of EBS short. 11.38% of Emergent BioSolutions' shares are currently sold short. Learn More on Emergent BioSolutions' current short interest. What is a good short interest ratio for Emergent BioSolutions? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EBS shares currently have a short interest ratio of 2.0. Learn More on Emergent BioSolutions's short interest ratio. Which institutional investors are shorting Emergent BioSolutions? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Emergent BioSolutions: Wolverine Trading LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Emergent BioSolutions? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.38% of Emergent BioSolutions' floating shares are currently sold short. Is Emergent BioSolutions' short interest increasing or decreasing? Emergent BioSolutions saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 5,700,000 shares, an increase of 16.1% from the previous total of 4,910,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Emergent BioSolutions' float size? Emergent BioSolutions currently has issued a total of 52,390,000 shares. Some of Emergent BioSolutions' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Emergent BioSolutions currently has a public float of 50,070,000 shares. How does Emergent BioSolutions' short interest compare to its competitors? 11.38% of Emergent BioSolutions' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Emergent BioSolutions: Bolt Biotherapeutics, Inc. (8.20%), Regulus Therapeutics Inc. (9.44%), Fortress Biotech, Inc. (14.08%), Rigel Pharmaceuticals, Inc. (2.86%), Vanda Pharmaceuticals Inc. (4.57%), Verastem, Inc. (3.10%), XOMA Co. (2.36%), PDS Biotechnology Co. (16.77%), IO Biotech, Inc. (0.16%), Cartesian Therapeutics, Inc. (5.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Emergent BioSolutions stock? Short selling EBS is an investing strategy that aims to generate trading profit from Emergent BioSolutions as its price is falling. EBS shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Emergent BioSolutions? A short squeeze for Emergent BioSolutions occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EBS, which in turn drives the price of the stock up even further. How often is Emergent BioSolutions' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EBS, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: BOLT Short Interest Data RGLS Short Interest Data FBIO Short Interest Data RIGL Short Interest Data VNDA Short Interest Data VSTM Short Interest Data XOMA Short Interest Data PDSB Short Interest Data IOBT Short Interest Data RNAC Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:EBS) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold[Urgent!] Generational Wealth GameplanCrypto 101 MediaIRS Loophole Gives Americans An Escape From InflationBirch GoldThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group